Wyzga Michael S
- SEC CIK
- 0001201256
No open-market purchases or sales filed in the past year.
Current role at each company
- TVRD Tvardi Therapeutics, Inc.Directoras of Jun 11, 2026
- MREO Mereo BioPharma Group plcDirectoras of Feb 27, 2026
- XFOR X4 Pharmaceuticals, IncDirectoras of Jan 5, 2026
- IVVD Invivyd, Inc.Directoras of May 25, 2023
- LogicBio Therapeutics, Inc.Directoras of Nov 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wyzga Michael S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XFOR X4 Pharmaceuticals, Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 (view filing) | Aug 18 | 4 days | Wyzga Michael SDirector | PPurchase | +25.0K | $1.20 | +$30.0K | +48.4%76.7K after |